AMAT

Applied Materials
D

AMAT

Arincen83/100B
369.42
USD
-12.36
(-3.24%)
Post Trading·365.00USD-4.42(-1.20%)
Last updated: · Delayed 15 min
Fair value473.28Plus-22%355Price 369.42592
Q4 FY2026 · Earnings report
EPS estimate 4.06Revenue estimate 10.30B
OverviewFinancialsSignalsNewsForecastEarningsDividendsCompany

Applied Materials net income 1985–2026

Applied Materials earned 2.54B USD in Q3 FY2026, the three months to 26 July 2026, up 42.7% on the same quarter a year before. Applied Materials's net income over the last twelve months was 9.27B USD, up 35.6% on the twelve months before. In fiscal year 2025 it earned 7.00B USD, down 2.5% on the year before.

Last updated 3 Nov 2026 · Next report 12 Nov 2026

Net income

Net income · +17.7% a year over 10 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM26 Jul 20269.27B+35.64%30.05%30.84B
FY202526 Oct 20257.00B-2.49%24.67%28.37B
FY202427 Oct 20247.18B+4.68%26.41%27.18B
FY202329 Oct 20236.86B+5.07%25.86%26.52B
FY202230 Oct 20226.53B+10.82%25.31%25.79B
FY202131 Oct 20215.89B+62.70%25.53%23.06B
FY202031 Oct 20203.62B+33.74%21.04%17.20B
FY201927 Oct 20192.71B-10.93%18.52%14.61B
FY201828 Oct 20183.04B-13.67%18.19%16.71B
FY201729 Oct 20173.52B+104.47%23.94%14.70B
FY201630 Oct 20161.72B+24.98%15.90%10.83B
FY201531 Oct 20151.38B+28.45%14.26%9.66B
FY201426 Oct 20141.07B+318.75%11.82%9.07B
FY201327 Oct 2013256.00M+134.86%3.41%7.51B
FY201228 Oct 2012109.00M-94.34%1.25%8.72B
FY201130 Oct 20111.93B+105.36%18.31%10.52B
FY201031 Oct 2010937.87M—9.82%9.55B
FY200931 Oct 2009-305.33M-131.78%-6.09%5.01B
FY200826 Oct 2008960.75M-43.82%11.82%8.13B
FY200728 Oct 20071.71B+12.76%17.57%9.73B
FY200629 Oct 20061.52B+25.35%16.54%9.17B
FY200530 Oct 20051.21B-10.46%17.30%6.99B
FY200431 Oct 20041.35B—16.86%8.01B
FY200326 Oct 2003-149.15M-155.44%-3.33%4.48B
FY200227 Oct 2002269.00M-65.30%5.31%5.06B
FY200128 Oct 2001775.23M-62.43%10.56%7.34B
FY200029 Oct 20002.06B+189.06%21.58%9.56B
FY199931 Oct 1999713.88M+157.10%14.69%4.86B
FY199831 Oct 1998277.67M-44.30%6.87%4.04B
FY199726 Oct 1997498.50M-16.86%12.24%4.07B
FY199627 Oct 1996599.60M+32.04%14.47%4.14B
FY199529 Oct 1995454.10M+105.75%14.83%3.06B
FY199430 Oct 1994220.70M+121.36%13.30%1.66B
FY199331 Oct 199399.70M+152.41%9.23%1.08B
FY199231 Oct 199239.50M+50.76%5.26%751.40M
FY199131 Oct 199126.20M-23.17%4.10%638.60M
FY199031 Oct 199034.10M-33.79%6.01%567.10M
FY198931 Oct 198951.50M+28.75%10.26%501.80M
FY198831 Oct 198840.00M+13,233.33%11.03%362.80M
FY198731 Oct 1987300.00K-75.00%0.17%174.40M
FY198631 Oct 19861.20M-87.10%0.80%149.30M
FY198531 Oct 19859.30M—5.33%174.60M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Applied Materials's profit

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.